Pojsakorn Danpanichkul MD , Kanokphong Suparan MD , Thanida Auttapracha , Primrose Tothanarungroj , Siwanart Kongarin , Krittameth Rakwong , Darren Jun Hao Tan MBBS , Banthoon Sukphutanan MD , Mark D. Muthiah MBBS , Daniel Tung MD , Junpeng Luo MD , Asahiro Morishita MD , En Ying Tan MD , Hirokazu Takahashi MD , Omar Y. Mousa MD , Rashid N. Lui MBBS , Mazen Noureddin MD , Donghee Kim MD , Denise M. Harnois DO , Ju Dong Yang MD , Karn Wijarnpreecha MD
{"title":"早发性胃肠道癌症和代谢危险因素:来自2021年全球疾病负担研究的全球趋势","authors":"Pojsakorn Danpanichkul MD , Kanokphong Suparan MD , Thanida Auttapracha , Primrose Tothanarungroj , Siwanart Kongarin , Krittameth Rakwong , Darren Jun Hao Tan MBBS , Banthoon Sukphutanan MD , Mark D. Muthiah MBBS , Daniel Tung MD , Junpeng Luo MD , Asahiro Morishita MD , En Ying Tan MD , Hirokazu Takahashi MD , Omar Y. Mousa MD , Rashid N. Lui MBBS , Mazen Noureddin MD , Donghee Kim MD , Denise M. Harnois DO , Ju Dong Yang MD , Karn Wijarnpreecha MD","doi":"10.1016/j.mayocp.2024.10.021","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To explore the increasing incidence of gastrointestinal (GI) cancers and related risk factors in younger patients.</div></div><div><h3>Patient and Methods</h3><div>We used data from the Global Burden of Disease Study 2021 to assess the incidence, mortality, and disability-adjusted life years (DALYs) for early-onset (age 15 to 49 years) GI cancers, including mortality and DALYs from diabetes mellitus and high body mass index.</div></div><div><h3>Results</h3><div>In 2021, there were approximately 499,800 incident cases, 285,900 deaths, and 14.01 million DALYs from early-onset GI cancer. Early-onset GI cancer accounted for 9.51% of the incidence and 7.73% of the mortality of the overall GI cancer. From 2000 to 2021, age-standardized incidence rates increased for early-onset colorectal cancer (annual percent change, 0.84%; 95% CI, 0.71% to 0.97%<strong><em>)</em></strong> and biliary tract cancer (annual percent change, 0.19%; 95% CI, 0.06% to 0.32%). In 2021, there were 20,860 deaths from early-onset GI cancer attributable to metabolic risk factors. The age-standardized death rates of early-onset GI cancer from metabolic risk factors increased in all types of early-onset GI cancer.</div></div><div><h3>Conclusion</h3><div>Our research highlights a significant increase in early-onset GI cancer, emphasizing the need for a strategy that includes controlling risk factors, particularly metabolic risk factors, adoption of effective screening methods, and effective cancer management.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"100 7","pages":"Pages 1159-1171"},"PeriodicalIF":6.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021\",\"authors\":\"Pojsakorn Danpanichkul MD , Kanokphong Suparan MD , Thanida Auttapracha , Primrose Tothanarungroj , Siwanart Kongarin , Krittameth Rakwong , Darren Jun Hao Tan MBBS , Banthoon Sukphutanan MD , Mark D. Muthiah MBBS , Daniel Tung MD , Junpeng Luo MD , Asahiro Morishita MD , En Ying Tan MD , Hirokazu Takahashi MD , Omar Y. Mousa MD , Rashid N. Lui MBBS , Mazen Noureddin MD , Donghee Kim MD , Denise M. Harnois DO , Ju Dong Yang MD , Karn Wijarnpreecha MD\",\"doi\":\"10.1016/j.mayocp.2024.10.021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To explore the increasing incidence of gastrointestinal (GI) cancers and related risk factors in younger patients.</div></div><div><h3>Patient and Methods</h3><div>We used data from the Global Burden of Disease Study 2021 to assess the incidence, mortality, and disability-adjusted life years (DALYs) for early-onset (age 15 to 49 years) GI cancers, including mortality and DALYs from diabetes mellitus and high body mass index.</div></div><div><h3>Results</h3><div>In 2021, there were approximately 499,800 incident cases, 285,900 deaths, and 14.01 million DALYs from early-onset GI cancer. Early-onset GI cancer accounted for 9.51% of the incidence and 7.73% of the mortality of the overall GI cancer. From 2000 to 2021, age-standardized incidence rates increased for early-onset colorectal cancer (annual percent change, 0.84%; 95% CI, 0.71% to 0.97%<strong><em>)</em></strong> and biliary tract cancer (annual percent change, 0.19%; 95% CI, 0.06% to 0.32%). In 2021, there were 20,860 deaths from early-onset GI cancer attributable to metabolic risk factors. The age-standardized death rates of early-onset GI cancer from metabolic risk factors increased in all types of early-onset GI cancer.</div></div><div><h3>Conclusion</h3><div>Our research highlights a significant increase in early-onset GI cancer, emphasizing the need for a strategy that includes controlling risk factors, particularly metabolic risk factors, adoption of effective screening methods, and effective cancer management.</div></div>\",\"PeriodicalId\":18334,\"journal\":{\"name\":\"Mayo Clinic proceedings\",\"volume\":\"100 7\",\"pages\":\"Pages 1159-1171\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mayo Clinic proceedings\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0025619624006165\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mayo Clinic proceedings","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0025619624006165","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021
Objective
To explore the increasing incidence of gastrointestinal (GI) cancers and related risk factors in younger patients.
Patient and Methods
We used data from the Global Burden of Disease Study 2021 to assess the incidence, mortality, and disability-adjusted life years (DALYs) for early-onset (age 15 to 49 years) GI cancers, including mortality and DALYs from diabetes mellitus and high body mass index.
Results
In 2021, there were approximately 499,800 incident cases, 285,900 deaths, and 14.01 million DALYs from early-onset GI cancer. Early-onset GI cancer accounted for 9.51% of the incidence and 7.73% of the mortality of the overall GI cancer. From 2000 to 2021, age-standardized incidence rates increased for early-onset colorectal cancer (annual percent change, 0.84%; 95% CI, 0.71% to 0.97%) and biliary tract cancer (annual percent change, 0.19%; 95% CI, 0.06% to 0.32%). In 2021, there were 20,860 deaths from early-onset GI cancer attributable to metabolic risk factors. The age-standardized death rates of early-onset GI cancer from metabolic risk factors increased in all types of early-onset GI cancer.
Conclusion
Our research highlights a significant increase in early-onset GI cancer, emphasizing the need for a strategy that includes controlling risk factors, particularly metabolic risk factors, adoption of effective screening methods, and effective cancer management.
期刊介绍:
Mayo Clinic Proceedings is a premier peer-reviewed clinical journal in general medicine. Sponsored by Mayo Clinic, it is one of the most widely read and highly cited scientific publications for physicians. Since 1926, Mayo Clinic Proceedings has continuously published articles that focus on clinical medicine and support the professional and educational needs of its readers. The journal welcomes submissions from authors worldwide and includes Nobel-prize-winning research in its content. With an Impact Factor of 8.9, Mayo Clinic Proceedings is ranked #20 out of 167 journals in the Medicine, General and Internal category, placing it in the top 12% of these journals. It invites manuscripts on clinical and laboratory medicine, health care policy and economics, medical education and ethics, and related topics.